Article
Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.
Cell death & disease - 21 May 2024
Staebler Sebastian, Rottensteiner-Brandl Ulrike, El Ahmad Zubeir, Kappelmann-Fenzl Melanie, Arkudas Andreas, Kengelbach-Weigand Annika, Bosserhoff Anja-Katrin, Schmidt Sonja K
Abstract excerpt
Malignant melanoma, the most aggressive form of skin cancer, is often incurable once metastatic dissemination of cancer cells to distant organs has occurred. We investigated the role of Transcription Factor Activating Enhancer-Binding Protein 2ε (AP2ε) in the progression of metastatic melanoma. Here, we observed that AP2ε is a potent activator of metastasis and newly revealed AP2ε to be an important player in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
